Obesity Trial, Recruiting NCT06335810 Sponsor: Weill Medical College of Cornell University Condition: Obesity
Back to Obesity

Obesity Trial, Recruiting

NCT06335810
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Main participant (called the "Index Participant"):

  • People who identify as Black or Hispanic
  • Men or women aged 18 or older
  • People with a body mass index (BMI) over 30, as measured by study staff
  • People who have access to a home computer or smartphone and are willing to use a food tracking app
  • People who can identify at least one adult in their social circle (such as a friend or family member) who is also willing to take part in the study

Social network member (the person from the main participant's social circle):

  • Men or women aged 18 or older
  • People who have access to the internet or a smartphone

Who may not be able to join:

Main participant:

  • People who are currently enrolled in a weight-loss program, taking weight-loss medications, or planning to have weight-loss surgery
  • People with serious health conditions, dementia, a current hospitalisation, injury, or pregnancy that would prevent regular physical activity
  • People who are not cleared for exercise based on a standard health questionnaire or who have not received clearance from a doctor (confirm with trial site)
  • People who are currently experiencing ongoing food insecurity
  • People who speak a language other than English or Spanish

Social network member:

  • People who speak a language other than English or Spanish

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Erica G Phillips, MD, MS, Weill Medical College of Cornell University

Phone: 646-962-5037

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
5 April 2024
Est. completion
31 December 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Number of participants who have attended at least 75 percent of the behavioral coaching sessions; Number of intervention participants who have at least one social network member engage in the study; Number of participants and social network members combined who complete the final study assessment

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov